Point72 Asset Management
CNTA

Point72 Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Point72 Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
+5,900
New +$151K ﹤0.01% 3458

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Point72 Asset Management's CNTA Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Centessa Pharmaceuticals (CNTA) in Q1 2026: 307,355 shares worth $12.2M. The stake represents 0.02% of the portfolio and ranks #1107 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in CNTA as recently as Q3 2025.

Point72 Asset Management first reported a position in CNTA in Q2 2021 and has held it in 19 quarters since. The position peaked at $57.4M in Q4 2024. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Point72 Asset Management held 307,355 shares of Centessa Pharmaceuticals worth $12.2M as of Q1 2026.
  • Centessa Pharmaceuticals was a new Point72 Asset Management position in Q1 2026.
  • Centessa Pharmaceuticals made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #1107 holding.
  • Point72 Asset Management first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • Point72 Asset Management's Centessa Pharmaceuticals position peaked at $57.4M in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.